Expression and effects of inhibition of type I insulin-like growth factor receptor tyrosine kinase in mantle cell lymphoma

by Vishwamitra, Deeksha, Shi, Ping, Wilson, Desiree, Manshouri, Roxsan, Vega, Francisco, Schlette, Ellen J., Amin, Hesham M.
Published 2011

p53 Expression by Immunohistochemistry is an Independent Determinant of Survival in Chronic Lymphocytic Leukemia Patients Receiving Frontline Chemo-Immunotherapy

by Schlette, Ellen J, Admirand, Joan, Wierda, William, Abruzzo, Lynne, O'Brien, Susan, Lerner, Susan, Keating, Michael J, Tam, Constantine
Published in Leuk Lymphoma (2009)

Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression

by Admirand, Joan H., Knoblock, Ronald J., Coombes, Kevin R., Tam, Constantine, Schlette, Ellen J., Keating, Michael J., Luthra, Rajyalakshmi, Medeiros, L. Jeffrey, Abruzzo, Lynne V.
Published 2010

Expression of serine 194–phosphorylated Fas-associated death domain protein correlates with proliferation in B-cell non–Hodgkin lymphomas

by Drakos, Elias, Leventaki, Vasiliki, Atsaves, Vasileios, Schlette, Ellen J., Lin, Pei, Vega, Francisco, Miranda, Roberto N., Claret, Francois-Xavier, Medeiros, L. Jeffrey, Rassidakis, George Z.
Published 2011

mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells

by Chen, Weina, Drakos, Elias, Grammatikakis, Ioannis, Schlette, Ellen J, Li, Jiang, Leventaki, Vasiliki, Staikou-Drakopoulou, Efi, Patsouris, Efstratios, Panayiotidis, Panayiotis, Medeiros, L Jeffrey, Rassidakis, George Z
Published 2010

Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia

by Ferrajoli, Alessandra, Lee, Bang-Ning, Schlette, Ellen J., O'Brien, Susan M., Gao, Hui, Wen, Sijin, Wierda, William G., Estrov, Zeev, Faderl, Stefan, Cohen, Evan N., Li, Changping, Reuben, James M., Keating, Michael J.
Published 2008

Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia

by Falchi, Lorenzo, Keating, Michael J., Marom, Edith M., Truong, Mylene T., Schlette, Ellen J., Sargent, Rachel L., Trinh, Long, Wang, Xuemei, Smith, Susan C., Jain, Nitin, Estrov, Zeev, O’Brien, Susan, Wierda, William G., Lerner, Susan, Ferrajoli, Alessandra
Published 2014

Achieving complete remission in CLL patients treated with ibrutinib: clinical significance and predictive factors

by Strati, Paolo, Schlette, Ellen J., Solis Soto, Luisa M., Duenas, Daniela E., Sivina, Mariela, Kim, Ekaterina, Keating, Michael J., Wierda, William G., Ferrajoli, Alessandra, Kantarjian, Hagop, Estrov, Zeev, Jain, Nitin, Thompson, Philip A., Wistuba, Ignacio I., Burger, Jan A.
Published in Blood (2020)

Whole-Genome Scanning by Array Comparative Genomic Hybridization as a Clinical Tool for Risk Assessment in Chronic Lymphocytic Leukemia

by Gunn, Shelly R., Mohammed, Mansoor S., Gorre, Mercedes E., Cotter, Philip D., Kim, Jaeweon, Bahler, David W., Preobrazhensky, Sergey N., Higgins, Russell A., Bolla, Aswani R., Ismail, Sahar H., de Jong, Daphne, Eldering, Eric, van Oers, Marinus H.J., Mellink, Clemens H.M., Keating, Michael J., Schlette, Ellen J., Abruzzo, Lynne V., Robetorye, Ryan S.
Published 2008

A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma

by Lyapichev, Kirill A., Piña-Oviedo, Sergio, Medeiros, L. Jeffrey, Evans, Mark G., Liu, Hui, Miranda, Alonso R., Hunt, Kelly K., Clemens, Mark W., Stewart, John M., Amin, Mitual B., Quesada, Andres E., Chai, Siaw Ming, Napoli, Arianna Di, Yoga, Arthy, Dave, Sanat K., Wistuba, Ignacio I., Wu, Yun, Bueso-Ramos, Carlos E., Schlette, Ellen J., Ferrufino-Schmidt, Maria C., Loghavi, Sanam, Khoury, Joseph D., Young, Ken H., Miranda, Roberto N.
Published in Mod Pathol (2019)